JESSICA MERIWETHER: Open Payments
NPI 1568777159 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,772 in 84 payments from 25 companies in 2025. Trend: 2023 $1,727 · 2024 $4,018 · 2025 $2,772
Food & beverage: $2,052Consulting: $500Education: $220
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $601 |
| Sumitomo Pharma America, Inc. | 11 | $323 |
| Janssen Biotech, Inc. | 12 | $298 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $254 |
| Astellas Pharma US Inc | 3 | $220 |
| Medtronic, Inc. | 2 | $167 |
| Novartis Pharmaceuticals Corporation | 6 | $156 |
| PFIZER INC. | 4 | $100 |
| UROGEN PHARMA, INC. | 4 | $87 |
| Ferring Pharmaceuticals Inc. | 4 | $75 |
Products named: BOTOX, GEMTESA, ERLEADA, Nubeqa, XTANDI, PLUVICTO, ALTAVIVA, ADSTILADRIN.
Industry payments across IN — which companies pay providers there.
